EAU guidelines offer updated guidance on diagnosis, treatment, & follow-up of patients with metastatic & muscle-invasive ...

A research team led by Professor Lee Sang-chul of the Department of Urology at Seoul National University Bundang Hospital ...

Blood in urine may signal serious issues—from infections to cancers. Experts stress early evaluation, especially in older ...

Detalimogene voraplasmid gains FDA RMAT designation, showcasing a 71% response rate in treating high-risk, BCG-unresponsive ...

Women are more prone to UTIs, for some, these infections become chronic due to hormonal fluctuations, hygiene practices, structural abnormalities in the urinary tract ...

That means, if Harry were a real-life patient, there’d be reason to believe his disease was advanced. “It could still be local”—which means it hasn’t yet spread beyond the prostate—“but it would take ...

An issue in the kidney or urinary tract can be painful and inconvenient. It can disrupt day-to-day life and have a significant impact on overall well-being. While it may seem […] ...

Consumer Reports has no financial relationship with any advertisers on this site.

Dr. Jason Kim and Dr. Steven Weissbart of the Women's Pelvic Health and Continence Center at Stony Brook University Hospital ...

In a multi-institutional study published in Science Direct, researchers revealed that testing urine-based tumor DNA (utDNA) ...

Stony Brook University Hospital pioneers catheter-free bladder monitoring with Bright Uro's wireless Glean system, designed to improve comfort and diagnostic accuracy.

The FDA designates the TOBY Test as a breakthrough device, revolutionizing bladder cancer detection with a non-invasive, ...